Product
DS-1211b
1 clinical trial
1 indication
Indication
Pseudoxanthoma elasticumClinical trial
A Phase 2, 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of DS-1211b in Individuals With PseudoXanthoma ElasticumStatus: Active (not recruiting), Estimated PCD: 2024-04-01